期刊文献+

绝经期泌尿生殖综合征治疗及健康管理的研究进展 被引量:7

Advances in treatment and health management genitourinary syndrome of menopause
在线阅读 下载PDF
导出
摘要 绝经期泌尿生殖综合征(GSM)发病率高,严重影响绝经后女性生活质量。自GSM的概念提出以来,关于如何提高其诊疗规范并在原有的基础上寻求更安全有效的治疗方式,国内外的研究从未间断,近年来对泌尿道症状的治疗也逐渐成为研究热点。目前激素补充仍是GSM的经典治疗方法,但考虑到长期用药的安全性且激素使用存在禁忌,一些新兴治疗如选择性雌激素受体调节剂、阴道脱氢表雄酮及激光治疗等,也成为可供选择的治疗方案。更重要的是,GSM的治疗并非仅限于短期干预,还应加强患者的自我认知,并对其进行长期健康管理,从而达到满意的治疗效果。该文就GSM的治疗进展及健康管理策略作一综述。 Genitourinary syndrome of menopause(GSM)seriously affects the quality of life of postmenopausal women with high incidence.Since the concept of GSM was put forward,researches on how to improve its diagnosis and treatment norms and seek more safe and effective treatments have never been stopped.In recent years,the treatment of urinary tract symptoms has attracted increasing attention.Hormone therapy is still the standard treatment for GSM now.Considering the safety of long-term use and contraindications of hormone therapy,however,some emerging treatments such as selective estrogen receptor modulator,vaginal dehydroepiandrosterone and laser therapy have also become alternative options.More importantly,the treatment of GSM shouldn′t be limited to short-term intervention,and it does make sense to improve self-awareness of patients and carry out long-term health management,which can contribute to a satisfactory result.This article reviews the advances in the treatment of GSM and introduces some health management strategies.
作者 舒涵(综述) 熊正爱(审校) SHU Han;XIONG Zheng′ai(Department of Obstetrics and Gynecology,the Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
出处 《重庆医学》 CAS 2020年第15期2572-2576,共5页 Chongqing medicine
基金 国家自然科学基金面上项目(81671415)。
关键词 绝经期泌尿生殖综合征 性功能 激素治疗 健康管理 综述 genitourinary syndrome of menopause sexual function hormone therapy health management review
  • 相关文献

参考文献4

二级参考文献34

  • 1Santos I, Clissold S.Urogenital disorders associated with oe- strogen deficiency: the role of promestriene as topical oestrogen therapy.Gynecol Endocrinol, 2010, 26:644-651.
  • 2Salvatore S, Nappi RE, Zerbinati N, et al.A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric, 2014, 17:363-369.
  • 3Tella SH, Gallagher JC. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomo- tor symptoms associated with the menopause.Expert Opin Phar- macother, 2013, 14:2407-2420.
  • 4Sharifi M, Lewiecki EM.Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen com- plex therapy.Expert Rev Clin Pharmacol, 2014,7:281-291.
  • 5Nappi RE, Martini E, Martella S, et al. Maintaining sexuality in menopause.Post Reprod Health, 2014, 20:22-29.
  • 6Anderson RR,Parrish JA.Selective photothermolysis: precise mi- crosurgery by selective absorption of pulsed radiation.Science, 1983,220:524-527.
  • 7Capon A, Mordon S.Canthermal lasers promote skin wound healing? Am J Clin Dermatol, 2003, 4: 1- 12.
  • 8谭军.激光皮肤再生美容.长沙:湖南科学技术出版社,2014:104-112.
  • 9Gaspar A, Addamo G,Brandi H.Vaginal fractional CO, laser: A minimally invasive. Am J Cosmet Surg, 2011,28:156-162.
  • 10Salvatore S, Nappi RE, Parma M, et al.Sexual function after fractional microablative CO2 laser in women with vulvovagi- nalatrophy. Climacteric, 2015, 18:219-225.

共引文献228

同被引文献109

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部